Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Saul

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Toxicologic Pathology|March 29, 2026
Mini Review: Carcinogenicity StatisticsJim Saul
Pharmaceutical Statistics|December 13, 2019
Discussion on statistical analysis of carcinogenicity studies with an early terminated treated groupJim Saul, Kelly Ashcroft-Hawley
Pharmaceutical Statistics|October 23, 2010
Review of the statistical analysis of the dog telemetry studyMike Aylott, Simon Bate, Susie Collins, et al.
Pharmaceutical Statistics|December 6, 2011
An assessment of the statistical methods used to analyse toxicology studiesPhilip Jarvis, Jim Saul, Mike Aylott, et al.
Pharmaceutical Statistics|December 1, 2011
Recommendations on the statistical analysis of the Comet assayJonathan Bright, Mike Aylott, Simon Bate, et al.
Mutagenesis|December 4, 2019
The 3D reconstructed skin micronucleus assay: considerations for optimal protocol designDarren Kidd, Sarah Phillips, Teresa Chirom, et al.
Toxicologic Pathology|April 8, 2026
Carcinogenicity in the 21st Century: Data Interpretation-Session 4Sandra De Jonghe, Matthew Jacobsen, Jim Saul, et al.
International Journal of Toxicology|October 28, 2025
Two-Year Inhalation Studies in Mice and Rats With HFO-1234ze(E), a Near Zero Global Warming Potential Propellant for Use in Pressurized Metered Dose InhalersPaul Giffen, Matthew Jacobsen, James Cartwright, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Toxicologic Pathology|March 29, 2026
Mini Review: Carcinogenicity StatisticsJim Saul
Pharmaceutical Statistics|December 13, 2019
Discussion on statistical analysis of carcinogenicity studies with an early terminated treated groupJim Saul, Kelly Ashcroft-Hawley
Pharmaceutical Statistics|October 23, 2010
Review of the statistical analysis of the dog telemetry studyMike Aylott, Simon Bate, Susie Collins, et al.
Pharmaceutical Statistics|December 6, 2011
An assessment of the statistical methods used to analyse toxicology studiesPhilip Jarvis, Jim Saul, Mike Aylott, et al.
Pharmaceutical Statistics|December 1, 2011
Recommendations on the statistical analysis of the Comet assayJonathan Bright, Mike Aylott, Simon Bate, et al.
Mutagenesis|December 4, 2019
The 3D reconstructed skin micronucleus assay: considerations for optimal protocol designDarren Kidd, Sarah Phillips, Teresa Chirom, et al.
Toxicologic Pathology|April 8, 2026
Carcinogenicity in the 21st Century: Data Interpretation-Session 4Sandra De Jonghe, Matthew Jacobsen, Jim Saul, et al.
International Journal of Toxicology|October 28, 2025
Two-Year Inhalation Studies in Mice and Rats With HFO-1234ze(E), a Near Zero Global Warming Potential Propellant for Use in Pressurized Metered Dose InhalersPaul Giffen, Matthew Jacobsen, James Cartwright, et al.
Pageof 1